COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Changes to guidance from the Centers for Disease Control and Prevention (CDC) have left nurses who test positive for COVID-19 questioning how best to protect their patients.
A new page on the Food and Drug Administration (FDA) website explains how genetic mutations in the COIVID-19 virus may impact the accuracy of existing tests for SARS-CoV-2.
In line with recent court rulings, on Dec. 2 the Centers for Medicare and Medicaid Services (CMS) paused enforcement of its rule
The Centers for Disease Control and Prevention (CDC) updated its list of high-risk conditions for
Operational planning information for pediatric COVID-19 vaccination is now available on the website
Last week, the Biden-Harris Administration announced $2.1 billion in American Rescue Plan funding will be used to improve infection prevention and control activities across
The Food and Drug Administration (FDA) alerted clinical laboratory staff and health care providers last week of a potential for false positive results with the Abbot Alinity
To address the unique challenges the COVID-19 pandemic produced for people with intellectual and developmental disabilities, the Centers for Disease Control and Prevention
The American Hospital Association (AHA) is reminding members they may request a delay of their next survey by the Centers for Medicare & Medicaid Services
The Centers for Disease Control and Prevention (CDC) released data this week affirming the safety of COVID-19 vaccines early in pregnancy.